← FDA DRUG APPROVALS

FDA ANDA · ANDA210698

SUCCINYLCHOLINE

Sponsor: DR REDDYS

APPLICATION
ANDA210698
TYPE
ANDA
ORIGINAL APPROVAL
2019-08-02
LATEST ACTION
2022-09-22
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SUCCINYLCHOLINE CHLORIDEPrescription
SUCCINYLCHOLINE CHLORIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

2022-09-22Labeling · Supplement 9 · standardAP
2021-10-25Labeling · Supplement 7 · standardAP
2021-02-11Labeling · Supplement 6 · standardAP
2019-08-02UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →